• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medicaid expansion tied to increase in prescriptions for diabetes drugs, birth control

April 20, 2017 By Sarah Faulkner

Prescription drugs

The number of prescriptions filled by adults using Medicaid rose 19% in states that expanded Medicaid compared to states that did not under the Affordable Care Act, according to a new study from the Harvard T.H. Chan School of Public Health.

The largest increases were for drugs that help patients deal with chronic conditions, including diabetes.

“We knew the Medicaid expansion had improved access to care, but this study gives us much more detail about what that really means for patient care. Medications for conditions like diabetes and heart disease can be life-savers,” co-author Benjamin Sommers said in prepared remarks.

Then-president Barack Obama’s sweeping healthcare legislation expanded Medicaid eligibility in certain states to millions of adults in 2014.

The team of Harvard researchers looked at pharmacy transaction data from 2013 to 2015 and compared the number of prescriptions filled in states that expanded Medicaid and those that did not. The team also considered the source of insurance coverage for each prescription.

Over the 1st year and a half of the Medicaid expansion, prescriptions for diabetes drugs grew by 24% – the largest growth among all types of drugs. Contraceptives, cardiovascular drugs and mental health medicines also saw large increases within expansion states.

The team also noted that within expansion states, regions with more uninsured people prior to the ACA experienced the largest increases in prescription drug utilization after the healthcare bill went into effect.

Increases in prescription drug usage were greater in regions with larger Hispanic and black populations. The researchers reported that this could support the hypothesis that Medicaid expansion may help to close ethic and racial disparities in terms of medication access.

Lawmakers on Capitol Hill are battling it out over the future of healthcare, with some hoping to preserve the ACA and others fighting for repeal and replacement.

In late March, Republican leaders pulled their ACA replacement bill from the U.S. House of Representatives due to a shortage of votes. Now reports have said they are nearing completion for a new bill.

Filed Under: Diabetes, Featured, Pharmaceuticals, Policy Tagged With: Capitol Hill, Harvard University

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS